INTELLIGENT BIO SOLUTIONS INC. financial data

Symbol
INBS on Nasdaq
Location
New York, NY
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 12 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 129% % -11%
Quick Ratio 13% % -13%
Debt-to-equity 103% % 40%
Return On Equity -205% % -40%
Return On Assets -99% % -19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,603,783 shares -70%
Common Stock, Shares, Outstanding 1,238,434 shares -74%
Entity Public Float $6,585,683 USD 10%
Common Stock, Value, Issued $12,384 USD -74%
Weighted Average Number of Shares Outstanding, Basic 950,829 shares 110%
Weighted Average Number of Shares Outstanding, Diluted 950,829 shares 110%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $902,138 USD -0.61%
Revenue from Contract with Customer, Excluding Assessed Tax $3,581,322 USD 18%
Cost of Revenue $1,926,347 USD 31%
General and Administrative Expense $9,594,725 USD 9.6%
Operating Income (Loss) $11,290,195 USD -5%
Nonoperating Income (Expense) $44,700 USD -308%
Net Income (Loss) Attributable to Parent $11,294,226 USD -5.6%
Earnings Per Share, Basic 0.49 USD/shares -80%
Earnings Per Share, Diluted 0.49 USD/shares -80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $740,371 USD -67%
Accounts Receivable, after Allowance for Credit Loss, Current $456,657 USD 72%
Inventory, Net $590,246 USD -16%
Other Assets, Current $480,133 USD 38%
Assets, Current $12,174,684 USD 200%
Property, Plant and Equipment, Net $321,741 USD -40%
Operating Lease, Right-of-Use Asset $1,887,178 USD 933%
Intangible Assets, Net (Excluding Goodwill) $3,269,439 USD -16%
Assets $17,653,042 USD 103%
Employee-related Liabilities, Current $470,486 USD 13%
Accrued Liabilities, Current $1,189,858 USD 96%
Liabilities, Current $5,127,241 USD 16%
Operating Lease, Liability, Noncurrent $1,529,064 USD 10420%
Liabilities $6,763,231 USD 51%
Accumulated Other Comprehensive Income (Loss), Net of Tax $266,079 USD 58%
Retained Earnings (Accumulated Deficit) $68,193,661 USD -20%
Stockholders' Equity Attributable to Parent $11,093,132 USD 154%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $10,889,811 USD 159%
Liabilities and Equity $17,653,042 USD 103%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,846,825 USD -19%
Net Cash Provided by (Used in) Financing Activities $3,558,165 USD 8282%
Net Cash Provided by (Used in) Investing Activities $70,401 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 1,238,446 shares -74%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $640,196 USD
Deferred Tax Assets, Valuation Allowance $12,698,469 USD 22%
Deferred Tax Assets, Gross $12,713,685 USD 22%
Operating Lease, Liability $84,659 USD -76%
Payments to Acquire Property, Plant, and Equipment $70,401 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $10,920,881 USD -0.95%
Lessee, Operating Lease, Liability, to be Paid $86,910 USD -78%
Property, Plant and Equipment, Gross $339,489 USD -46%
Operating Lease, Liability, Current $382,518 USD 86%
Lessee, Operating Lease, Liability, to be Paid, Year Two $83,509 USD -73%
Lessee, Operating Lease, Liability, to be Paid, Year One $86,910 USD -72%
Operating Lease, Weighted Average Discount Rate, Percent 0.132 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,251 USD -94%
Preferred Stock, Shares Issued 0 shares
Additional Paid in Capital $79,540,489 USD 29%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $927,638 USD -2.7%
Depreciation, Depletion and Amortization $257,907 USD 6.7%
Deferred Tax Assets, Net of Valuation Allowance $15,216 USD